By Biogen. In the event of a material breach of this Agreement by C4, which material breach remains uncured for [***] measured from the date of written notice of such material breach by Biogen that identifies the material breach and the actions or conduct that Biogen considers would be an acceptable cure of such material breach, Biogen may terminate this Agreement in whole or with respect to one or more Development Candidates, Products, or Collaboration Targets at any time during the Term of this Agreement by written notice of termination to C4.
Appears in 2 contracts
Sources: Collaborative Research and License Agreement (C4 Therapeutics, Inc.), Collaborative Research and License Agreement (C4 Therapeutics, Inc.)